CSL Ltd
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of CSL-AX would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1994) — listing | $1,013,841 20.7× | $1,427,118 20.3× |
| Year 6 (1999) | $262,108 6.3× | $371,117 6.2× |
| Year 11 (2004) | $107,905 3.2× | $154,977 3.2× |
| Year 16 (2009) | $37,777 1.4× | $54,661 1.4× |
| Year 21 (2014) | $12,769 0.7× | $18,408 0.7× |
| Year 26 (2019) | $4,608 0.4× | $6,665 0.4× |
| Year 31 (2024) | $1,631 0.4× | $2,361 0.4× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with CSL
For illustration only — not investment advice. Past performance is not indicative of future results.